Repligen
RGEN
#2575
Rank
S$8.53 B
Marketcap
S$151.52
Share price
-0.46%
Change (1 day)
0.52%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): S$0.10 Billion

According to Repligen 's latest financial reports the company's current earnings are S$0.73 Billion. , an increase over its 2024 earnings that were of -S$8.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 S$0.10 B-1430.84%
2024 -S$8.12 Million-113.01%
2023 S$62.33 M-78.01%
2022 S$0.28 B33.37%
2021 S$0.21 B131.52%
2020 S$91.79 M101.31%
2019 S$45.59 M25.93%
2018 S$36.2 M105.61%
2017 S$17.61 M-11.46%
2016 S$19.89 M14.91%
2015 S$17.3 M20.26%
2014 S$14.39 M-51.49%
2013 S$29.67 M90.98%
2012 S$15.53 M
2010 S$0.22 M-103.81%
2009 -S$5.91 Million-223.84%
2008 S$4.76 M
2006 -S$3.21 Million229.64%
2005 -S$0.98 Million-89.16%
2004 -S$8.97 Million-16.86%
2003 -S$10.78 Million88.72%
2002 -S$5.72 Million-27.88%
2001 -S$7.92 Million-1.74%
2000 -S$8.06 Million85.93%
1999 -S$4.34 Million159.16%
1998 -S$1.68 Million85.71%
1997 -S$0.91 Million-70.83%
1996 -S$3.09 Million-72.41%
1995 -S$11.2 Million-60.63%
1994 -S$28.44 Million45.39%
1993 -S$19.56 Million39.45%
1992 -S$14.03 Million-32.3%
1991 -S$20.72 Million6.62%
1990 -S$19.43 Million1577.78%
1989 -S$1.16 Million-57.14%
1988 -S$2.71 Million-362.5%
1987 S$1.02 M-130.77%
1986 -S$3.35 Million136.36%
1985 -S$1.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.11 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$9.40 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$13.94 B 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.00 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.15 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$0.48 B 346.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.81 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.15 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.62 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-S$0.13 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA